CDH1 and neoplasm: Among the studies that evaluated the correlation of the reduction of the above mentioned marker expression with the tumor site, only Ahmed et al. [22] and Goulioumios et al. [24] found significance when observing less expression of E-cadherin (p = 0.002) and β-catenin (p = 0.025), respectively, at the supraglottic site.